Table II.
EIM | CDC | ANZARDa | |
---|---|---|---|
Recorded patient characteristics | |||
Age of the female patient | Yes | Yes | Yes |
Age of the partner or husband | No | No | Yes |
Medical indication for treatment | No | Yes | Yes |
Treatment outline | |||
Initiated cycles | Yes | Yes | Yes |
Aspiration done or not | Yes | Yes | Yes |
Elective single embryo transfer | No | Since 2008 | No |
Embryo stage at transfer | Yes | No | Yes |
Freeze-all | Since 2017 | Yes | Yes |
Cryopreservation technology | No | No | Yes |
Number of transferred embryos | Yes | Yes | Yes |
Outcome data | |||
Pregnancy | Yes | Yes | Yes |
Miscarriage | No | No | Yes |
Other abnormal pregnancy outcomes | No | No | Yes |
Delivery | Yes | Yes | Yes |
Mode of delivery | No | No | Yes |
Cumulative outcome data | Yes, 1 year | No | Yes |
Multiple delivery | Yes | Yes | Yes |
Preterm delivery <37 weeks | Yes | Since 2011 | Yes |
Neonatal birthweight | No | Yes | Yes |
Neonatal malformation | No | No | Yes |
Perinatal mortality | No | No | Yes |
Complications | |||
OHSS | Yes | No | Yes |
Maternal deaths | Yes | No | 1999b |
Haemorrhage | Yes | No | No |
Infections | Yes | No | No |
Foetal reduction | Yes | No | Yesc |
See also Table 15.1 in Chambers et al. (2019).
Six cases of maternal death were mentioned 1999.
The number of foetal reductions is combined with terminations of pregnancy.
OHSS, ovarian hyperstimulation syndrome.